Planning for the next influenza H1N1 season: A modelling study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Carrat, Fabrice ^a,b,c   Pelat, Camille ^a,b   Levy Bruhl, Daniel ^d   Bonmarin, Isabelle ^d   Lapidus, Nathanael ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CROSS PROTECTION; FLU LIKE SYNDROME; FRANCE; HEALTH SERVICE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNITY; INCIDENCE; INFANT; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MODEL; PANDEMIC INFLUENZA; SEASON; SEROCONVERSION; SIMULATION; FEMALE; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MALE; MIDDLE AGED; NEWBORN; PANDEMIC; PRESCHOOL CHILD; STATISTICAL MODEL; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; PANDEMICS; VACCINATION; YOUNG ADULT;

EID: 77958078089     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-301     Document Type: Article

References (54)

1. Valleron AJ, Guidet B. Real-time comparative monitoring of the A/H1N1 pandemic in France. Clin Microbiol Infect 2010, 16:393-396. 10.1111/j.1469-0691.2010.03166.x, 20121818.
2. Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). Euro Surveill 2009, 14:pii. 19204.
3. Baker MG, Wilson N, Huang QS, Paine S, Lopez L, Bandaranayake D, Tobias M, Mason K, Mackereth GF, Jacobs M, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009, 14:pii. 19319.
4. Turbelin C, Pelat C, Boelle PY, Levy-Bruhl D, Carrat F, Blanchon T, Hanslik T. Early estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases. Euro Surveill 2009, 14:pii. 19341.
5. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-1887. 10.1001/jama.2009.1536, 19822626.
6. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-1879. 10.1001/jama.2009.1496, 19822627.
7. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902. 10.1001/jama.2009.1583, 19887665.
8. Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ, Grajales-Muniz C, Robles-Perez E, Gonzalez-Leon M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascon-Pacheco RA, Borja-Aburto VH. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374:2072-2079. 10.1016/S0140-6736(09)61638-X, 19913290.
9. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458. 10.1016/S0140-6736(09)61304-0, 19643469.
10. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009, 361:2507-2517. 10.1056/NEJMoa0906612, 20007555.
11. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, Miller MA. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009, 361:674-679. 10.1056/NEJMoa0904023, 19564633.
12. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944. 10.1056/NEJMoa0906695, 19815859.
13. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010, 362:27-35. 10.1056/NEJMoa0910444, 20032319.
14. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-689. 10.1056/NEJMoa0904252, 19564631.
15. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, et al. Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection. N Engl J Med 2010, 362:1708-1719. 10.1056/NEJMra1000449, 20445182.
16. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58:521-524.
17. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952. 10.1056/NEJMoa0906453, 19745214.
18. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010,
19. Flahault A, de Lamballerie X, Hanslik T. Symptomatic infections less frequent with H1N1pdm than with seasonal strains: Antoine Flahault, Xavier de Lamballerie, Camille Pelat, Nicolas Salez, Thomas Hanslik. PLoS Curr Influenza 2009, RRN1140.
20. Carrat F, Luong J, Lao H, Salle AV, Lajaunie C, Wackernagel H. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med 2006, 4:26. 10.1186/1741-7015-4-26, 1626479, 17059593.
21. Carrat F, Flahault A, Boussard E, Farran N, Dangoumau L, Valleron AJ. Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health 1998, 52(Suppl 1):32S-38S.
22. Garnerin P, Saidi Y, Valleron AJ. The French Communicable Diseases Computer Network. A seven-year experiment. Ann N Y Acad Sci 1992, 670:29-42. 10.1111/j.1749-6632.1992.tb26072.x, 1309100.
23. Pelat C, Boelle PY, Cowling BJ, Carrat F, Flahault A, Ansart S, Valleron AJ. Online detection and quantification of epidemics. BMC Med Inform Decis Mak 2007, 7:29. 10.1186/1472-6947-7-29, 2151935, 17937786.
24. Carrat F, Sahler C, Rogez S, Leruez-Ville M, Freymuth F, Le Gales C, Bungener M, Housset B, Nicolas M, Rouzioux C. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med 2002, 162:1842-1848. 10.1001/archinte.162.16.1842, 12196082.
25. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167:775-785. 10.1093/aje/kwm375, 18230677.
26. Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 2009, 28:372-375. 10.1097/INF.0b013e318191eef7, 19295464.
27. Population de la France métropolitaine. , http://www.ined.fr/fr/pop_chiffres/france/
28. Barabasi AL, Albert R. Emergence of scaling in random networks. Science 1999, 286:509-512. 10.1126/science.286.5439.509, 10521342.
29. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5:e74. 10.1371/journal.pmed.0050074, 2270306, 18366252.
30. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 2006, 164:936-944. 10.1093/aje/kwj317, 16968863.
31. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006, 442:448-452. 10.1038/nature04795, 16642006.
32. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, Kent CK, Finelli L, Ferguson NM. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009, 361:2619-2627. 10.1056/NEJMoa0905498, 20042753.
33. White LF, Wallinga J, Finelli L, Reed C, Riley S, Lipsitch M, Pagano M. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respi Viruses 2009, 3:267-276. 10.1111/j.1750-2659.2009.00106.x, 19903209.
34. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009, 324:1557-1561. 10.1126/science.1176062, 19433588.
35. Suess T, Buchholz U, Dupke S, Grunow R, Matthias An der H, Heider A, Biere B, Schweiger B, Haas W, Krause G. Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009. Am J Epidemiol 2010,
36. Smith PG, Rodrigues LC, Fine PE. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984, 13:87-93. 10.1093/ije/13.1.87, 6698708.
37. Prise en charge médicale des malades atteints de grippe et de leurs contacts en situation de pandémie. , http://www.pandemie-grippale.gouv.fr/IMG/pdf/Fiche_D3-4.pdf
38. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithaworn S, Burke DS. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005, 437:209-214. 10.1038/nature04017, 16079797.
39. Finkenstadt BF, Morton A, Rand DA. Modelling antigenic drift in weekly flu incidence. Stat Med 2005, 24:3447-3461. 10.1002/sim.2196, 16217845.
40. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862. 10.1016/j.vaccine.2007.07.027, 17719149.
41. Ross T, Zimmer S, Burke D, Crevar C, Carter D, Stark J, Giles B, Zimmerman R, Ostroff S, Lee B. Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. PLoS Curr Influenza 2010, RRN1148.
42. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA. Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus. Science 2010, 2897825, 20339031.
43. Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol 2010, 84:3127-3130. 10.1128/JVI.02184-09, 2826039, 20042511.
44. Viboud C, Bjornstad ON, Smith DL, Simonsen L, Miller MA, Grenfell BT. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006, 312:447-451. 10.1126/science.1125237, 16574822.
45. Chowell G, Nishiura H, Bettencourt LM. Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface 2007, 4:155-166. 10.1098/rsif.2006.0161, 2358966, 17254982.
46. Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect 2008, 136:852-864. 2680121,2680121, 17634159.
47. Nishiura H, Chowell G, Safan M, Castillo-Chavez C. Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1) 2009. Theor Biol Med Model 2010, 7:1. 10.1186/1742-4682-7-1, 2821365, 20056004.
48. Pastor-Satorras R, Vespignani A. Epidemic dynamics in finite size scale-free networks. Phys Rev E Stat Nonlin Soft Matter Phys 2002, 65:035108.
49. May RM, Lloyd AL. Infection dynamics on scale-free networks. Phys Rev E Stat Nonlin Soft Matter Phys 2001, 64:066112.
50. Barry JM, Viboud C, Simonsen L. Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain. J Infect Dis 2008, 198:1427-1434. 10.1086/592454, 18808337.
51. Nelson M, Spiro D, Wentworth D, Beck E, Fan J, Ghedin E, Halpin R, Bera J, Hine E, Proudfoot K, et al. The early diversification of influenza A/H1N1pdm. PLoS Curr Influenza 2009, RRN1126.
52. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998, 178:53-60.
53. Bansal S, Pourbohloul B, Hupert N, Grenfell B, Meyers LA. The shifting demographic landscape of pandemic influenza. PLoS One 2010, 5:e9360. 10.1371/journal.pone.0009360, 2829076, 20195468.
54. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, Finelli L, Biedrzycki P, Lipsitch M. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009, 6:e1000207. 10.1371/journal.pmed.1000207, 2784967, 19997612.